Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The jellyfish nematocyst is a specialized stinging organelle contained within cnidocytes, primarily located on the tentacles of cnidarians (Britannica, 2024). It serves as a high-pressure micro-injection system used for prey capture and defense, capable of discharging a venomous tubule with extreme acceleration of up to 5.4 million g (Holstein et al., 2006). The associated chemoreceptive apparatus consists of sensory receptors that detect chemical cues from prey or predators, integrating these signals with mechanical stimuli to regulate the firing mechanism (Kass-Simon & Scappaticci, 2002). This complex is a significant target for topical preventatives, such as Safe Sea, which aim to deactivate the stinging mechanism before contact by mimicking self-recognition or blocking chemical pathways (Safe Sea, 2024). Drugs like lidocaine have been shown to inhibit discharge by blocking the voltage-gated ion channels, such as nCaV, essential for the electrical signaling that triggers the process (Zimmermann et al., 2020). Understanding this apparatus is critical for developing effective first-aid treatments, as certain substances like vinegar can either inhibit or stimulate discharge depending on the jellyfish species (Ward et al., 2012). Failure to properly manage the nematocyst apparatus during a sting can lead to severe envenomation, resulting in symptoms ranging from localized pain and dermatitis to systemic cardiovascular collapse (Tibballs et al., 2011).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Jellyfish nematocyst capsule and associated chemoreceptive apparatus.